Annual report
1783.TEDINET S100SJVK
Period2022-10-01 → 2023-09-30
Filed2023-12-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 134
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.6bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥5.0bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥6.9bn | 2020-10-01 → 2021-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.5bn | 2019-10-01 → 2020-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.3bn | 2018-10-01 → 2019-09-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.5bn | 2022-10-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥76m | 2021-10-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.5bn | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥51m | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥217m | 2020-10-01 → 2021-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.3bn | 2019-10-01 → 2020-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥282m | 2018-10-01 → 2019-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.5bn | 2022-10-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥717m | 2021-10-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.1bn | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥804m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥977m | 2020-10-01 → 2021-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥3.7bn | 2019-10-01 → 2020-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥37m | 2018-10-01 → 2019-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.1bn | 2022-10-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | −¥768m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥7.5bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥7.5bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥5.3bn | at 2021-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥10.3bn | at 2020-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥14.2bn | at 2019-09-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.1bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥2.2bn | at 2022-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.4bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.2bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.4bn | at 2021-09-30d | Cons. | Net assets |
| Net assets / equity | ¥3.8bn | at 2020-09-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥7.8bn | at 2019-09-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.8bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.8bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.6bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.7bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2021-09-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥468m | at 2020-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥836m | at 2019-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.7bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥2.0bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.3bn | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥290m | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥3.0bn | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥230m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.4bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥1.1bn | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥233m | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.8bn | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥656m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.1bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.7bn | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥132m | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.2bn | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥6.21 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.75 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-16.48 | 2020-10-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-64.44 | 2019-10-01 → 2020-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.64 | 2018-10-01 → 2019-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥37.19 | at 2023-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥30.64 | at 2022-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥50.93 | at 2021-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥64.77 | at 2020-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥135.63 | at 2019-09-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 83.8% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.9% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.5% | at 2021-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.7% | at 2020-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.9% | at 2019-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 18.4% | 2022-10-01 → 2023-09-30 | Cons. | Rate of return on equity (5-year summary) |
| Employees | 21 | at 2023-09-30 | Cons. | Number of employees |
| Employees | 27 | at 2022-09-30 | Cons. | Number of employees |
| Employees | 35 | at 2021-09-30d | Cons. | Number of employees |
| Employees | 174 | at 2020-09-30d | Cons. | Number of employees |
| Employees | 180 | at 2019-09-30d | Cons. | Number of employees |
| Revenue | ¥1.0bn | 2022-10-01 → 2023-09-30 | Standalone | Net sales |
| Revenue | ¥851m | 2021-10-01 → 2022-09-30 | Standalone | Net sales |
| Revenue | ¥5.0bn | 2020-10-01 → 2021-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥493m | 2019-10-01 → 2020-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥355m | 2018-10-01 → 2019-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | −¥405m | 2022-10-01 → 2023-09-30 | Standalone | Operating income |
| Operating income | −¥593m | 2021-10-01 → 2022-09-30 | Standalone | Operating income |
| Ordinary income | −¥539m | 2022-10-01 → 2023-09-30 | Standalone | Ordinary income |
| Ordinary income | −¥1.1bn | 2021-10-01 → 2022-09-30 | Standalone | Ordinary income |
| Ordinary income | −¥316m | 2020-10-01 → 2021-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.1bn | 2019-10-01 → 2020-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥303m | 2018-10-01 → 2019-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥539m | 2022-10-01 → 2023-09-30 | Standalone | Income before income taxes |
| Profit before tax | −¥1.4bn | 2021-10-01 → 2022-09-30 | Standalone | Income before income taxes |
| Net income | −¥367m | 2022-10-01 → 2023-09-30 | Standalone | Profit loss |
| Net income | −¥1.1bn | 2021-10-01 → 2022-09-30 | Standalone | Profit loss |
| Net income | −¥418m | 2020-10-01 → 2021-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | −¥4.2bn | 2019-10-01 → 2020-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | −¥613m | 2018-10-01 → 2019-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥7.7bn | at 2023-09-30 | Standalone | Assets |
| Total assets | ¥7.6bn | at 2022-09-30 | Standalone | Assets |
| Total assets | ¥4.2bn | at 2021-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥8.1bn | at 2020-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥12.2bn | at 2019-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥451m | at 2023-09-30 | Standalone | Liabilities |
| Total liabilities | ¥105m | at 2022-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥7.2bn | at 2023-09-30 | Standalone | Net assets |
| Net assets / equity | ¥7.4bn | at 2022-09-30 | Standalone | Net assets |
| Net assets / equity | ¥3.7bn | at 2021-09-30d | Standalone | Net assets |
| Net assets / equity | ¥3.8bn | at 2020-09-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥7.9bn | at 2019-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥170m | at 2023-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥322m | at 2022-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥-2.17 | 2022-10-01 → 2023-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.61 | 2021-10-01 → 2022-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.05 | 2020-10-01 → 2021-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-72.24 | 2019-10-01 → 2020-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-10.67 | 2018-10-01 → 2019-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥41.9 | at 2023-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥43.87 | at 2022-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥56.32 | at 2021-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥64.82 | at 2020-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥138.24 | at 2019-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 93.1% | at 2023-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 97.5% | at 2022-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.4% | at 2021-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.5% | at 2020-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.8% | at 2019-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 170,042,851 | at 2023-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 167,942,851 | at 2022-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 65,992,851 | at 2021-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 58,442,851 | at 2020-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 57,442,851 | at 2019-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 10 | at 2023-09-30 | Standalone | Number of employees |
| Employees | 11 | at 2022-09-30 | Standalone | Number of employees |
| Employees | 16 | at 2021-09-30d | Standalone | Number of employees |
| Employees | 20 | at 2020-09-30d | Standalone | Number of employees |
| Employees | 14 | at 2019-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 63
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-10-01 → 2023-09-30 | ¥45m |
| Reconciling Itemsreconciling | depreciation | 2022-10-01 → 2023-09-30 | −¥27,000 |
| Reconciling Itemsreconciling | segment assets | at 2023-09-30 | ¥1.7bn |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-09-30 | −¥521m |
| Health Carereportable segment | capex | 2022-10-01 → 2023-09-30 | ¥301,000 |
| Health Carereportable segment | depreciation | 2022-10-01 → 2023-09-30 | ¥636,000 |
| Health Carereportable segment | employees | at 2023-09-30 | 2 pure |
| Health Carereportable segment | revenue | 2022-10-01 → 2023-09-30 | ¥708m |
| Health Carereportable segment | revenue external | 2022-10-01 → 2023-09-30 | ¥708m |
| Health Carereportable segment | segment assets | at 2023-09-30 | ¥1.2bn |
| Health Carereportable segment | segment profit | 2022-10-01 → 2023-09-30 | −¥81m |
| Real Estatereportable segment | capex | 2022-10-01 → 2023-09-30 | ¥22m |
| Real Estatereportable segment | depreciation | 2022-10-01 → 2023-09-30 | ¥10m |
| Real Estatereportable segment | employees | at 2023-09-30 | 11 pure |
| Real Estatereportable segment | revenue | 2022-10-01 → 2023-09-30 | ¥9.9bn |
| Real Estatereportable segment | revenue external | 2022-10-01 → 2023-09-30 | ¥9.9bn |
| Real Estatereportable segment | segment assets | at 2023-09-30 | ¥4.6bn |
| Real Estatereportable segment | segment profit | 2022-10-01 → 2023-09-30 | ¥2.2bn |
| Real Estate Consultingreportable segment | employees | at 2023-09-30 | 2 pure |
| Real Estate Consultingreportable segment | revenue | 2022-10-01 → 2023-09-30 | ¥23m |
| Real Estate Consultingreportable segment | revenue external | 2022-10-01 → 2023-09-30 | ¥23m |
| Real Estate Consultingreportable segment | segment assets | at 2023-09-30 | ¥75m |
| Real Estate Consultingreportable segment | segment profit | 2022-10-01 → 2023-09-30 | −¥67m |
| —segment total | capex | 2022-10-01 → 2023-09-30 | ¥23m |
| —segment total | depreciation | 2022-10-01 → 2023-09-30 | ¥11m |
| —segment total | employees | at 2023-09-30 | 15 pure |
| —segment total | revenue | 2022-10-01 → 2023-09-30 | ¥10.6bn |
| —segment total | revenue external | 2022-10-01 → 2023-09-30 | ¥10.6bn |
| —segment total | segment assets | at 2023-09-30 | ¥5.8bn |
| —segment total | segment profit | 2022-10-01 → 2023-09-30 | ¥2.0bn |
| Reconciling Itemsreconciling | revenue | 2021-10-01 → 2022-09-30 | −¥9m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-10-01 → 2022-09-30 | −¥9m |
| Reconciling Itemsreconciling | segment assets | at 2022-09-30 | ¥753m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-09-30 | −¥1.0bn |
| Health Carereportable segment | capex | 2021-10-01 → 2022-09-30 | ¥2m |
| Health Carereportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥171,000 |
| Health Carereportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥369m |
| Health Carereportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥369m |
| Health Carereportable segment | segment assets | at 2022-09-30 | ¥425m |
| Health Carereportable segment | segment profit | 2021-10-01 → 2022-09-30 | ¥7m |
| Real Estatereportable segment | capex | 2021-10-01 → 2022-09-30 | ¥21m |
| Real Estatereportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥25m |
| Real Estatereportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥4.1bn |
| Real Estatereportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥4.1bn |
| Real Estatereportable segment | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥9m |
| Real Estatereportable segment | segment assets | at 2022-09-30 | ¥6.1bn |
| Real Estatereportable segment | segment profit | 2021-10-01 → 2022-09-30 | ¥1.2bn |
| Real Estate Consultingreportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥6m |
| Real Estate Consultingreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥569m |
| Real Estate Consultingreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥569m |
| Real Estate Consultingreportable segment | segment assets | at 2022-09-30 | ¥145m |
| Real Estate Consultingreportable segment | segment profit | 2021-10-01 → 2022-09-30 | −¥126m |
| —segment total | capex | 2021-10-01 → 2022-09-30 | ¥23m |
| —segment total | depreciation | 2021-10-01 → 2022-09-30 | ¥31m |
| —segment total | revenue | 2021-10-01 → 2022-09-30 | ¥5.0bn |
| —segment total | revenue external | 2021-10-01 → 2022-09-30 | ¥5.0bn |
| —segment total | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥9m |
| —segment total | segment assets | at 2022-09-30 | ¥6.7bn |
| —segment total | segment profit | 2021-10-01 → 2022-09-30 | ¥1.1bn |
| Health Carereportable segment | employees | at 2023-09-30 | 1 pure |
| Real Estatereportable segment | employees | at 2023-09-30 | 1 pure |
| Real Estate Consultingreportable segment | employees | at 2023-09-30 | 2 pure |
| —segment total | employees | at 2023-09-30 | 4 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,423
| Item | Context | Value | Unit |
|---|---|---|---|
| Net increase decrease in cash and cash equivalents | Prior1YearDuration | -354885000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration | 846923000 | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | Prior1YearDuration | 8529000 | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | CurrentYearDuration | － | JPY |
| Cash and cash equivalents | Prior2YearInstant | 2085918000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1739563000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1739563000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 2586486000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 5 | |
| Accumulated depreciation ppe by group | Prior1YearInstant | -98688000 | JPY |
| Accumulated depreciation ppe by group | CurrentYearInstant | -47476000 | JPY |
| Write downs of inventories | Prior1YearDuration | 39897000 | JPY |
| Write downs of inventories | CurrentYearDuration | 83366000 | JPY |
| Payroll and allowances sga | Prior1YearDuration | 231900000 | JPY |
| Payroll and allowances sga | CurrentYearDuration | 152409000 | JPY |
| Directors compensations sga | Prior1YearDuration | 237193000 | JPY |
| Directors compensations sga | CurrentYearDuration | 196440000 | JPY |
| Taxes and dues sga | Prior1YearDuration | 119211000 | JPY |
| Taxes and dues sga | CurrentYearDuration | 107086000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration | 118000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration | 24000 | JPY |
| Provision for directors retirement benefits sga | Prior1YearDuration | -20743000 | JPY |
| Provision for directors retirement benefits sga | CurrentYearDuration | － | JPY |
| Depreciation sga | Prior1YearDuration | 13692000 | JPY |
| Depreciation sga | CurrentYearDuration | 10859000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YearDuration | － | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration | 3835000 | JPY |
| Amortization of goodwill | Prior1YearDuration | 382640000 | JPY |
| Amortization of goodwill | CurrentYearDuration | 327851000 | JPY |
| Advertising expenses sga | Prior1YearDuration | 54403000 | JPY |
| Advertising expenses sga | CurrentYearDuration | 66538000 | JPY |
| Commision fee paid | Prior1YearDuration | 280674000 | JPY |
| Commision fee paid | CurrentYearDuration | 211984000 | JPY |
| Provision for shareholder benefit program sga | Prior1YearDuration | 35000000 | JPY |
| Provision for shareholder benefit program sga | CurrentYearDuration | 64783000 | JPY |
| Research and development expenses sga | Prior1YearDuration | 4545000 | JPY |
| Research and development expenses sga | CurrentYearDuration | － | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00263-000RealEstateReportableSegmentMember | 4089397000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00263-000HealthCareReportableSegmentMember | 368667000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00263-000RealEstateConsultingReportableSegmentMember | 569226000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReportableSegmentsMember | 5027291000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YearDuration | 5027291000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E00263-000RealEstateReportableSegmentMember | 9000000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E00263-000HealthCareReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E00263-000RealEstateConsultingReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReportableSegmentsMember | 9000000 | JPY |
| Transactions with other segments | Prior1YearDuration_ReconcilingItemsMember | -9000000 | JPY |
| Transactions with other segments | Prior1YearDuration | － | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E00263-000RealEstateReportableSegmentMember | 4098397000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |